AU Patent

AU2022201947B2 — Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Assigned to Arqule Inc · Expires 2023-07-27 · 3y expired

What this patent protects

The present application provides solid forms of (R)-6-(2-fluorophenyl)-N-(3-(2-(2 methoxyethylamino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride, and methods of preparing and using same. 5

USPTO Abstract

The present application provides solid forms of (R)-6-(2-fluorophenyl)-N-(3-(2-(2 methoxyethylamino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine dihydrochloride, and methods of preparing and using same. 5

Drugs covered by this patent

Patent Metadata

Patent number
AU2022201947B2
Jurisdiction
AU
Classification
—
Expires
2023-07-27
Drug substance claim
No
Drug product claim
No
Assignee
Arqule Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.